A novel therapeutic approach to 6-OHDA-induced Parkinson’s disease in rats via supplementation of PTD-conjugated tyrosine hydroxylase
Authors:
- Ai Ling FuAFAi Ling Fu
- Yu Xia WangYWYu Xia Wang
- Lei Ping YuLYLei Ping Yu
- Pei Yuan JiaPJPei Yuan Jia
- Qian LiQLQian Li
- Guo Zhang JinGJGuo Zhang Jin
- Man Ji SunMSMan Ji Sun
- 1 July 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 346 (1) , 1-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's diseaseBrain Research Protocols, 2005
- Tyrosine hydroxylase replacement in experimental Parkinson’s disease with transvascular gene therapyNeuroRX, 2005
- Protein transduction: unrestricted delivery into all cells?Trends in Cell Biology, 2000
- Long-term phenotypic correction of rodent hemiparkinsonism by gene therapy using genetically modified myoblastsGene Therapy, 2000
- Prospects for new restorative and neuroprotective treatments in Parkinson's diseaseNature, 1999
- Quality of life and parkinson's disease: Translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39)Quality of Life Research, 1999
- Neostriatal mechanisms in Parkinson's diseaseNeurology, 1998
- EPIDEMIOLOGY OF PARKINSON'S DISEASENeurologic Clinics, 1996
- The role of tetrahydropteridines in the enzymatic conversion of tyrosine to 3,4-dihydroxyphenylalanineBiochemical and Biophysical Research Communications, 1964
- Tyrosine HydroxylaseJournal of Biological Chemistry, 1964